Primary Site >> Colorectal Cancer

Gene >> MYD88

  • 2006
  • 2008
  • 2009
  • 2010
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Intracellular expression of toll-like receptor 4 in neuroblastoma cells and their unresponsiveness to lipopolysaccharide.
PMID: 17156435
Ref: Toll-like receptor 5 engagement modulates tumor development and growth in a mouse xenograft model of human colon cancer.
PMID: 18538140
Ref: Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility.
PMID: 19551144
Ref: Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathway.
PMID: 19722233
Ref: Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells.
PMID: 19732721
Ref: High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer.
PMID: 20145615
Ref: Antitumor activity and immune response induction of a dual agonist of Toll-like receptors 7 and 8.
PMID: 20515950
Ref: TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells.
PMID: 20526283
Ref: Ligand-independent toll-like receptor signals generated by ectopic overexpression of MyD88 generate local and systemic antitumor immunity.
PMID: 20823152
Ref: The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models.
PMID: 22218775
Ref: TLR9 agonist protects mice from radiation-induced gastrointestinal syndrome.
PMID: 22238604
Ref: Mutational and expressional analyses of MYD88 gene in common solid cancers.
PMID: 23235763
Ref: Blockade of Myd88 signaling induces antitumor effects by skewing the immunosuppressive function of myeloid-derived suppressor cells.
PMID: 23184679
Ref: MyD88 in DNA repair and cancer cell resistance to genotoxic drugs.
PMID: 23766530
Ref: Repressing DNA repair to enhance chemotherapy: targeting MyD88 in colon cancer.
PMID: 23766531
Ref: Innate immunity gene polymorphisms and the risk of colorectal neoplasia.
PMID: 23803696
Ref: TLR9 signaling in the tumor microenvironment initiates cancer recurrence after radiotherapy.
PMID: 24154870
Ref: Functional TLR5 genetic variants affect human colorectal cancer survival.
PMID: 24154872
Ref: Alterations in the microbiota drive interleukin-17C production from intestinal epithelial cells to promote tumorigenesis.
PMID: 24412611
Ref: MyD88 adaptor-like (Mal) regulates intestinal homeostasis and colitis-associated colorectal cancer in mice.
PMID: 24603458
Ref: Graphene oxide triggers toll-like receptors/autophagy responses in vitro and inhibits tumor growth in vivo.
PMID: 24652749
Ref: Mutation and expression analysis of the IDH1, IDH2, DNMT3A, and MYD88 genes in colorectal cancer.
PMID: 24887488
Ref: Cell-intrinsic TLR2/MyD88 pathway in breast and colon cancer.
PMID: 25457615
Ref: Upregulation of TLRs and IL-6 as a marker in human colorectal cancer.
PMID: 25547486
Ref: Apple polysaccharide reduces NF-Kb mediated colitis-associated colon carcinogenesis.
PMID: 25412264
Ref: Diverse roles of STING-dependent signaling on the development of cancer.
PMID: 25639870
Ref: Enterobacteria-secreted particles induce production of exosome-like S1P-containing particles by intestinal epithelium to drive Th17-mediated tumorigenesis.
PMID: 25907800
Ref: Cell Free DNA of Tumor Origin Induces a 'Metastatic' Expression Profile in HT-29 Cancer Cell Line.
PMID: 26133168
Ref: Roles of TLR/MyD88/MAPK/NF-kappaB Signaling Pathways in the Regulation of Phagocytosis and Proinflammatory Cytokine Expression in Response to E. faecalis Infection.
PMID: 26317438
Ref: Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer.
PMID: 26712311
Ref: Diet- and Genetically-induced Obesity Produces Alterations in the Microbiome, Inflammation and Wnt Pathway in the Intestine of Apc(+/1638N) Mice: Comparisons and Contrasts.
PMID: 27698916
Ref: Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-kappaB, and Up-regulating Expression of MicroRNA-21.
PMID: 27876571
Ref: Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin.
PMID: 28179508
Ref: Induction of intestinal stemness and tumorigenicity by aberrant internalization of commensal non-pathogenic E. coli.
PMID: 28300841
Ref: Resistin causes G1 arrest in colon cancer cells through upregulation of SOCS3.
PMID: 28417458
Ref: Multi-factorial modulation of colorectal carcinoma cells motility - partial coordination by the tetraspanin Co-029/tspan8.
PMID: 28418857
Ref: Expression of pattern recognition receptor genes and mortality in patients with colorectal adenocarcinoma.
PMID: 28533893
Ref: Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy.
PMID: 28753429
Ref: Andrographolide suppresses proliferation of human colon cancer SW620 cells through the TLR4/NF-kappaB/MMP-9 signaling pathway.
PMID: 28943944
Ref: Leukotriene B4-receptor-1 mediated host response shapes gut microbiota and controls colon tumor progression.
PMID: 29209564
Ref: Loss of BMI-1 dampens migration and EMT of colorectal cancer in inflammatory microenvironment through TLR4/MD-2/MyD88-mediated NF-kappaB signaling.
PMID: 28815730
Ref: Parabacteroides distasonis attenuates toll-like receptor 4 signaling and Akt activation and blocks colon tumor formation in high-fat diet-fed azoxymethane-treated mice.
PMID: 29696632
Ref: Contribution of drugs acting on the TLRs/MyD88 signaling pathway on colitis-associated cancer.
PMID: 30001768
Ref: Activated ATF6 Induces Intestinal Dysbiosis and Innate Immune Response to Promote Colorectal Tumorigenesis.
PMID: 30063920
Ref: Dual functional roles of the MyD88 signaling in colorectal cancer development.
PMID: 30086464
Ref: Cell-type specific MyD88 signaling is required for intestinal tumor initiation and progression to malignancy.
PMID: 30221070
Ref: Cell-free DNA derived from cancer cells facilitates tumor malignancy through Toll-like receptor 9 signaling-triggered interleukin-8 secretion in colorectal cancer.
PMID: 30239551